{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:53:07Z","timestamp":1792079587677,"version":"4.4.0"},"reference-count":0,"publisher":"The Medical Letter, Inc.","issue":"1766","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Lett Drugs Ther"],"abstract":"<jats:p>Camizestrant (Etcamah \u2013 AstraZeneca), an oral estrogen receptor antagonist, has received accelerated approval from the FDA for use in combination with a cyclin-dependent kinase (CDK) 4\/6 inhibitor for treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative, locally advanced or metastatic breast cancer in adults who have ESR1 mutations that were detected in circulating tumor DNA (ctDNA) during treatment with an aromatase inhibitor and a CDK 4\/6 inhibitor.<\/jats:p>","DOI":"10.58347\/tml.2026.1766c","type":"journal-article","created":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:37:48Z","timestamp":1792078668000},"page":"173-174","source":"Crossref","is-referenced-by-count":0,"title":["Camizestrant (Etcamah) for Advanced Breast Cancer"],"prefix":"10.58347","volume":"68","member":"37151","published-online":{"date-parts":[[2026,10,26]]},"container-title":["The Medical Letter on Drugs and Therapeutics"],"original-title":[],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:37:48Z","timestamp":1792078668000},"score":1,"resource":{"primary":{"URL":"https:\/\/secure.medicalletter.org\/TML-article-1766c"}},"subtitle":[],"editor":[{"name":"Editors from The Medical Letter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,10,26]]},"references-count":0,"journal-issue":{"issue":"1766","published-online":{"date-parts":[[2026,10,26]]}},"URL":"https:\/\/doi.org\/10.58347\/tml.2026.1766c","relation":{},"ISSN":["1523-2859"],"issn-type":[{"value":"1523-2859","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,26]]}}}